AtriCure, Inc. (ATRC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Company Overview - AtriCure is focused on reducing the burden of atrial fibrillation (Afib) globally and alleviating pain after surgery [3] - The company aims to provide a comprehensive overview of its market opportunities and product portfolio [2] Market Opportunity - AtriCure identifies a significant market opportunity, estimating a potential annual market size of $10 billion [3] - The company emphasizes the strength of its product portfolio, which includes advanced technology and a robust pipeline supported by clinical evidence [3]